Bridgepoint-backed Swedish renal care provider Diaverum has announced plans to launch an initial public offering (IPO) on Nasdaq Stockholm.
Bridgepoint-backed Swedish renal care provider Diaverum has announced plans to launch an initial public offering (IPO) on Nasdaq Stockholm.